These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16556008)

  • 1. Can targeting apoptosis resolve the cancer saga?
    Dlamini Z; Mbita Z; Ledwaba T
    Future Oncol; 2005 Jun; 1(3):339-49. PubMed ID: 16556008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does "death receptor" signaling play a role in tumorigenesis and cancer therapy?
    Villunger A; Strasser A
    Oncol Res; 1998; 10(11-12):541-50. PubMed ID: 10367935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the apoptosis pathway in prostate cancer.
    Zielinski RR; Eigl BJ; Chi KN
    Cancer J; 2013; 19(1):79-89. PubMed ID: 23337761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells.
    Reuter S; Eifes S; Dicato M; Aggarwal BB; Diederich M
    Biochem Pharmacol; 2008 Dec; 76(11):1340-51. PubMed ID: 18755156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis.
    Fulda S; Meyer E; Friesen C; Susin SA; Kroemer G; Debatin KM
    Oncogene; 2001 Mar; 20(9):1063-75. PubMed ID: 11314043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of gene products involved in resistance to apoptosis in metastatic colon cancer cells: roles of Fas, Apaf-1, NFkappaB, IAPs, Smac/DIABLO, and AIF.
    Huerta S; Heinzerling JH; Anguiano-Hernandez YM; Huerta-Yepez S; Lin J; Chen D; Bonavida B; Livingston EH
    J Surg Res; 2007 Sep; 142(1):184-94. PubMed ID: 17603079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the extrinsic apoptotic pathway in cancer: lessons learned and future directions.
    Ashkenazi A
    J Clin Invest; 2015 Feb; 125(2):487-9. PubMed ID: 25642709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Targeting apoptosis signaling pathways in cancer therapy].
    Cheng L; Wang X; Zhang J; Zhang SB; Zheng SQ; Zheng J
    Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):639-42. PubMed ID: 20079200
    [No Abstract]   [Full Text] [Related]  

  • 9. Dual apoptotic effect of Xrel3 c-Rel/NF-kappaB homolog in human cervical cancer cells.
    Shehata M; Shehata M; Shehata F; Pater A
    Cell Biol Int; 2004; 28(12):895-904. PubMed ID: 15566959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caspases and cancer: mechanisms of inactivation and new treatment modalities.
    Philchenkov A; Zavelevich M; Kroczak TJ; Los M
    Exp Oncol; 2004 Jun; 26(2):82-97. PubMed ID: 15273659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cell death signalling: recent advances and therapeutic application].
    Ségal-Bendirdjian E; Dudognon C; Mathieu J; Hillion J; Besançon F
    Bull Cancer; 2005 Jan; 92(1):23-35. PubMed ID: 15689323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis pathways in cancer and cancer therapy.
    Debatin KM
    Cancer Immunol Immunother; 2004 Mar; 53(3):153-9. PubMed ID: 14749900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting apoptosis as an approach for gastrointestinal cancer therapy.
    Qiao L; Wong BC
    Drug Resist Updat; 2009 Jun; 12(3):55-64. PubMed ID: 19278896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helenalin bypasses Bcl-2-mediated cell death resistance by inhibiting NF-κB and promoting reactive oxygen species generation.
    Hoffmann R; von Schwarzenberg K; López-Antón N; Rudy A; Wanner G; Dirsch VM; Vollmar AM
    Biochem Pharmacol; 2011 Sep; 82(5):453-63. PubMed ID: 21669190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overcoming resistance of cancer cells to apoptosis.
    Hersey P; Zhang XD
    J Cell Physiol; 2003 Jul; 196(1):9-18. PubMed ID: 12767037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic targeting of apoptosis pathways in cancer.
    Ziegler DS; Kung AL
    Curr Opin Oncol; 2008 Jan; 20(1):97-103. PubMed ID: 18043263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis: A Target for Anticancer Therapy.
    Pfeffer CM; Singh ATK
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Apoptosis-reactivating agents for targeted anticancer therapy].
    Fil'chenkov AA
    Biomed Khim; 2013; 59(2):119-43. PubMed ID: 23789342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis signaling in tumor therapy.
    Fulda S; Debatin KM
    Ann N Y Acad Sci; 2004 Dec; 1028():150-6. PubMed ID: 15650241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-specific toxicity of apoptin is independent of death receptors but involves the loss of mitochondrial membrane potential and the release of mitochondrial cell-death mediators by a Nur77-dependent pathway.
    Maddika S; Booy EP; Johar D; Gibson SB; Ghavami S; Los M
    J Cell Sci; 2005 Oct; 118(Pt 19):4485-93. PubMed ID: 16179607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.